pentobarbital will lessen the extent or outcome of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Use of alternative treatment options is strongly advisable when linagliptin will be to be administered which has a CYP3A4 inducer
pentobarbital will lessen the extent or outcome of aripiprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will minimize the level or result of rolapitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Extended-time period coadministration of powerful CYP3A4 inducers with rolapitant may possibly appreciably lessen rolapitant efficacy.
pentobarbital will lessen the level or impact of phenytoin by influencing hepatic enzyme CYP2C9/ten metabolism. Use Caution/Observe.
Constantly check vital signals through sedation and recovery interval if coadministered. Meticulously titrate remimazolam dose if administered with opioid analgesics and/or sedative/hypnotics.
pentobarbital will reduce the extent or result of parecoxib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unfamiliar.
pentobarbital will reduce the extent or effect of doxorubicin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Ordering drug degrees in the blood or urine, proper laboratory tests, and imaging inside the crisis department.
pentobarbital will decrease the extent or influence of levoketoconazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Mysterious.
pentobarbital will lessen the extent or effect of bosentan by influencing hepatic enzyme CYP2C9/10 metabolism. Small/Significance Unknown.
pentobarbital will decrease the level or impact of bazedoxifene/conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital boosts toxicity of methoxyflurane by expanding metabolism. Contraindicated. Elevated metabolism more info of methoxyflurane to nephrotoxic compounds.
pentobarbital will lower the extent or result of clarithromycin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Not known.
Contraindicated (1)pentobarbital will reduce the level or effect of fostemsavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism.